You are on page 1of 26

HAIR

GROWTH

Baicapil
Stimulates
hair growth
and prevents
hair loss

www.provitalgroup.com
THE IMPORTANCE OF HAIR

Hair is a symbol of vitality and health, as well as part of society. People suffering from hair loss

being a key feature of the individuality and are generally perceived as older people who are

identity of a person. A gleaming hair in good physically and socially less attractive (Goh &

condition is one of the main attributes of beauty Zippin, 2009).

and contributes to having high self-confidence


Hair loss has been for many years a common
and self-esteem.
problem for dermatologists consultation. For

In the year 4000 BC, in ancient Egypt, hair was both men and women, it is extremely important

already documented as being important at a that hair is healthy, full of plenitude, movement

social and psychological level. Nowadays it still and freshness, as it directly influences our mood

plays this important role, and that is why hair and and character and it can define our professional,

scalp disorders cause ample frustration in a great personal and even sentimental success.

Baicapil, obtained from nature, is a combination of three botanical active ingredients that reduces
hair loss, stimulates growth and increases hair density.

With Baicapil, hair regains a healthy and strong condition.

V01-10/13 73800-1
HAIR BIOLOGY

STRUCTURE OF HAIR

Hair is a complex organ that includes the external part, known as the hair shaft, and the internal part, called
the hair follicle. The following parts can be distinguished inside the follicle, depending on the current phase
of the hair cycle (fig. 1):

ANAGEN TELOGEN

Shaft

Sebaceous gland

Hair erector
muscle

Bulge stem cells Bulge stem cells

Secondary germ stem


Dermal papilla
cells

Outer root
sheath

Secondary germ
stem cells

Dermal papilla

Fig. 1. Anagen and telogen phases of the hair cycle.

V01-10/13 73800-2
Multipotent stem cells are present in the follicle. These cells are self-renewing and differentiate into more
mature but less potent specialized cells. The division and differentiation of these cells can restore hair. For
this reason, they are directly related to hair growth and absence of hair loss.

Recent studies have shown that this group of stem cells is not homogenous, because it consists of two
biochemically and functionally distinct populations:

The first one, situated in the bulge, consists of the stem cells which are responsible for the
differentiation and growth of various cell types to produce pigmented hair (Paus & Cotsarelis,
1999).

The second one, which niche is called the secondary germ, consists of the progenitor cells. They
are the direct descendants of the bulge stem cells and are in contact with the dermal papilla,
which activates them to initiate and control hair growth (Myung et al., 2013).

The dermal papilla (DP) is a conglomerate of specialized fibroblasts that is involved in the morphogenesis
and hair cycle through the regulation of various cell types in the follicle. It contains stimulating factors for
the proliferation and differentiation of follicular keratinocytes, which induce the formation of a new hair
follicle (Kwack et al., 2013).

HAIR CYCLE

Each hair follicle is constantly subjected to cycles consisting of three stages: a stage of rapid growth and hair
shaft formation (anagen), followed by a regression stage based on apoptosis (catagen) and a resting period
of the hair follicle (telogen).

1. Anagen

During the initial stages of hair regeneration (end of the telogen phase/beginning of the anagen phase), the
hair follicle stem cells are quiescent (Rompolas et al., 2012).

The activation of the anagen phase starts with a signal from the dermal papilla towards the secondary germ
stem cells, which activate and proliferate in order to initiate hair growth. The bulge stem cells are the next
ones to activate and proliferate. These cells are responsible for extending the outer root sheath (it
separates the hair follicle from the dermis) and maintaining the matrix that supports hair growth (Myung et
al., 2013). These stem cells differentiate into matrix cells.

V01-10/13 73800-3
Then, matrix cells quickly proliferate to produce the hair shaft. Hair pigmentation is due to melanocytes
inserted between these cells (Paus & Cotsarelis, 1999).

Finally, the stem cells are silenced and return to a state of quiescence. In addition, during the transition
from the anagen phase to the catagen phase, proliferating cells in the matrix are induced into a coordinated
apoptosis (Plikus, 2012).

Approximately 85-90% of the follicles are in the anagen phase (Ritti et al., 2009), which usually lasts from 2
to 8 years (Paus & Cotsarelis, 1999). The duration of the anagen phase determines hair length, which varies
between individuals and declines with age.

2. Catagen

It is the end of the hair fiber production phase, when the follicle is subjected to a controlled process of
regression. Most follicular keratinocytes undergo apoptosis. Cell growth and pigmentation stop, the bulb is
separated from the dermal papilla and follicular shortening occurs (Paus & Cotsarelis, 1999).

It is the shortest phase of the cycle and it only lasts two to three weeks. Therefore, at any given time only
between 1% and 2% of the follicles are in the catagen phase (Restrepo, 2010).

At the end of this phase, the follicle retracts into the surface of the scalp (it does not protrude from the
dermis) and its size is significantly reduced.

3. Telogen

The telogen phase typically lasts from 2 to 4 months, before the follicles reenter the anagen phase and the
cycle starts again. Therefore, it determines when new hair is originated.

During this phase, the hair shaft matures into fully keratinized hair that detaches from the follicle (usually
due to hair combing or washing). Most people lose 50 to 150 hairs a day.

The percentage of follicles in the scalp in the telogen phase is from 5 to 15%. An increase in this percentage
leads to excessive hair loss (Paus & Cotsarelis, 1999).

V01-10/13 73800-4
HAIR LOSS

Approximately 5 million hair follicles cover the human body at birth. New follicles are not formed after
birth, but hair and follicle size may vary over time (Paus & Cotsarelis, 1999).

The daily loss of an average of 50 to 150 hairs is


considered as normal. It is a cycle under constant
renovation. The same way a person is born, grows and
dies, hair follows a very similar pattern: it grows, rests
and falls. The problem arises when this life cycle of hair
is altered and the common problem of alopecia appears.

Hair loss is caused by an alteration in the hair growth cycle, due to several factors (androgen metabolism,
genetics or stress). It is characterized by:

Changes in the ratio of anagen and telogen hair: the number of hairs in the anagen phase is
reduced and more hair remains in the telogen phase.
Shortening of the anagen phase: hair stops growing earlier than expected; it is shorter and thinner.
Extension of the telogen phase.

Some alopecias are considered as reversible, because the hair cycle is disturbed, but the hair follicles are
still present and they follow the hair cycle, even in bald scalps (Paus & Cotsarelis, 1999).

Baicapil

Taking into account the life cycle of hair, in order to


prevent hair loss it is desirable that the active ingredient
used has the ability to maintain a long anagen period and
a short telogen period, or the ability to change the hair
cycle gently from the telogen phase to the anagen phase.

In addition, it is also very important that it improves the


condition of the follicle cells and their microenvironment,
as this is a crucial factor in maintaining the balance between the anagen and telogen phases.

V01-10/13 73800-5
Baicapil is a combination of 3 plants (Scutellaria baicalensis, Triticum vulgare sprout and Glycine max
sprout) that increases cellular energy and activates follicle stem cells, while protecting them from
senescence. This way, it visibly fights hair loss by:

Stimulating hair growth.


Increasing hair density.
Reducing hair loss.
Recovering a healthy and strong appearance.

COMPOSITION

1. CHINESE SKULLCAP

Botany

Scutellaria baicalensis Georgi, known as Chinese skullcap or baical skullcap, is a source of baicalin, one of
the main actives of Baicapil.

It is a biennial perennial plant that can reach up to 1.2 m in height, with bluish purple flowers. Flowering is
from May to August. The English name skullcap describes the shape of the flower calyx, which resembles
the helmets that were used in the Middle Ages. The fruits appear in late August.

It grows mainly in China, Russia, Mongolia and the Korean Peninsula. The Lamiaceae family, to which S.
baicalensis belongs, includes more than 350 species, many of them medically active. It is one of the 50
fundamental herbs for traditional Chinese medicine, and it is also used in Nepal, Japan and Korea (Stutte et
al., 2008).

V01-10/13 73800-6
The root of S. baicalensis has been used for thousands of years to prepare Huang Qin, a traditional medicine
to cure nervousness, high blood pressure and respiratory problems, and to alleviate and detoxify fever
episodes (Stutte et al., 2008). Nowadays, Huang Qin is extensively used in the treatment of inflammatory
diseases, hepatitis, tumors and diarrhea in Southeast Asia. S. baicalensis is officially registered in the JPXIII
Japanese Pharmacopoeia and in the Chinese Pharmacopoeia.

Chemistry

The chemical composition of the roots of Asian Scutellaria


is characterized by its high content in flavonoids. Out of a
total of 26 identified flavonoids, five of them are C-
glycosides, twelve are O-glycosides and the remaining nine
are aglycones (Han et al., 2007). The characteristic
components of this root are baicalin (fig. 2), which is the
glucuronic derivative of baicalein (6-9%), wogonin-7-O-
glucuronideglucurinide (wogonoside) (2-8%), baicalein (0.1-
1.6%) and wogonin (0.01-0.3%).
Fig. 2. Chemical structure of baicalin.

The presence of other flavonoids in lower concentrations


has also been described, such as oroxylin A, visidulin, skullcapflavone II, neobaicalein, acteoside, chrysin and
their corresponding glucosides.

2. SOY AND WHEAT SPROUTS

Soy

Soy (Glycine max L.) is an annual herbaceous plant


that belongs to the Leguminosae family (Fabaceae).

Soy is characterized by being up to 1.5 m tall, with


trifoliate and hairy leaves that usually detach before
the seeds are ripe. The flowers are white-yellowish
or blue-violet in color and small in size. The fruit is a
hairy arched pod containing 2-6 smooth subglobose seeds, variable in color from white-yellowish to brown.

V01-10/13 73800-7
Soy originated in the Far East, where it has always been a basic food constituent. It is currently cultivated in
many temperate-warm regions of the planet.

Wheat

Triticum vulgare Vill., called wheat, belongs to the


Poaceae family, also known as Gramineae. It is a
vivacious herbaceous plant. The stems are simple and
hollow, with pointed leaves. The inflorescence is a
panicle or spikelets spike. The flowers produce a single
fruit, called grain or seed, which carries an embryo or
germ together with the reserve substance.

Wheat originated in ancient Mesopotamia, but it is cultivated worldwide, from the limits of the Artic to
areas close to the Equator. It is adaptable to different conditions, from xerophytic to coastal conditions.

Sprouts

Baicapil contains soy and wheat sprouts, rich in sugars. Germination comprises a number of physiological
processes that occur in the seeds of higher plants and that result in the transformation of the embryo into a
mature plant.

The process starts when the optimal conditions to ensure the proper use of the reserve material and the
obtaining of the expected biomolecules exist.

Reserve substances include:

Carbohydrates: starch, hemicelluloses, amyloids and galactomannans.

Proteins: peptides and free amino acids, in particular proline, glutamine, glutamic acid and
asparagine.

Lipids: the main reserve in the seeds are triglycerides, which hydrolyze transforming into glycerol
and unsaturated fatty acids, such as oleic acid, linoleic acid and linolenic acid.

Mineral elements: phosphate in the form of phytin and other cations (potassium, calcium and
magnesium).

V01-10/13 73800-8
The sprouts in Baicapil are obtained from seeds, using only water for germination, without pesticides or
other chemical additives. This process is stopped after 3 days, which is when active biomolecules reach
peak levels (peptides, amino acids, oligosaccharides, glucose).

MECHANISM OF ACTION OF Baicapil

The innovative mechanism of action of Baicapil offers effective results in both men and women.

1. METABOLISM OF GLUCOSE

Growing follicles use glucose almost two times faster than resting follicles in order to obtain cellular energy
(ATP). Glucose is degraded through glycolysis and the oxidative metabolism to provide the energy material,
but during this process oxygen is consumed and cellular respiration increases.

During the transformation of resting follicles into growing follicles, glycolysis increases by 200% and ATP
production through the respiratory chain augments by 270% (Adachi et al., 1970). It was also showed that
during the transition from the telogen to the anagen phase, DNA content and follicle size increase (Adachi
et al., 1999).

Baicapil provides additional sugars to the follicles, which enter the citric acid cycle and increase cellular
respiration. In in vitro assays with Baicapil, it can be seen that both isolated mitochondria and intact cells
increase oxygen consumption. This probably increases ATP production, providing the cellular energy
required for hair growth, development and maintenance. Baicapil also protects against oxidative stress,
which may appear as a result of high cellular energy production (ATP).

Therefore, the nutrients provided by Baicapil lead to more active and proliferating follicles. This
represents an induction to hair growth, increasing hair density and extending the anagen phase.

V01-10/13 73800-9
2. TERT (HUMAN REVERSE TRANSCRIPTASE)

TERT (human reverse transcriptase) is one of the characteristic proteins of stem and progenitor cells, which
is essential for their activation and functioning.

Activation of stem cells

As we mentioned earlier, quiescent stem cells are activated to produce a new hair.

It has been observed that TERT induces a rapid transition from the telogen to the anagen phase, facilitating
hair growth through the induction of quiescent stem cells to proliferation and mobilization. The result is the
growth of strong and resilient hair (Flores et al., 2005; Sarin et al., 2005; Choi et al., 2008).

Baicapil, through the activation of stem cells by inducing TERT expression, accelerates the initiation of
the anagen phase that originates a new hair strand.

Mitochondria protection

Oxidative stress is one of the mechanisms contributing to hair loss. Lipid peroxides induce apoptosis of the
hair follicle cells and the catagen phase is initiated prematurely (Treb, 2009).

It has been demonstrated that TERT protects neurons, fibroblasts and stem cells against oxidative stress.
Thus, in cells were TERT is overexpressed, mitochondrial DNA (mtDNA) is protected against oxidative
damage and fewer reactive oxygen species (ROS) are produced. All this is indicative of a better
mitochondrial function (Ahmed et al., 2008).

When mitochondria are damaged, a communication occurs towards the nucleus that results in the
expression of genes typical of cell senescence. By reducing mitochondrial damage, it can be stated that
TERT action leads to the rejuvenation of fibroblasts (Ahmed et al., 2008). All this helps to increase metabolic
energy and resistance against stress (Ahmed et al., 2008; Haendeler et al., 2009).

As a summary, it can be concluded that the induction of TERT expression originated by Baicapil protects
the follicle against oxidative stress and increases metabolic energy, thus extending the anagen phase of
hair, improving follicular activity and reducing hair loss.

V01-10/13 73800-10
Protection against senescence

It has been observed in vitro that dermal papilla (DP) cells in bald scalps suffer premature senescence,
compared to DP cells in normal scalps (Upton et al., 2013).

Baicapil induces TERT overexpression, improves mitochondrial function and protects against ROS, so
fibroblasts are protected against senescence and remain young and active.

KEY POINTS IN THE MECHANISM OF ACTION OF Baicapil

Baicapil provides nutrients and induces TERT overexpression in cells, leading to:

1. An increase in glycolysis and ATP production more active and vigorous follicles.

2. The activation of stem cells initiation of a new anagen phase, leading to hair growth and
greater hair density.

3. Mitochondrial DNA protection against oxidative stress and ROS reduction in stem cells and
fibroblasts more active and healthier cells, leading to a longer anagen phase and thicker and
denser hair.

4. The preservation of follicle fibroblasts from senescence for longer time, resulting in an extension
of the anagen phase.

IN VITRO EFFICACY

1. SOY AND WHEAT SPROUTS: OXYGEN CONSUMPTION

Thanks to the respiration process as a component of cell metabolism, aerobic cells obtain energy from the
oxidation of biomolecules (amino acids, glucose, fatty acids).

In order to evaluate the action of wheat and soy sprouts on cellular metabolism, especially on
mitochondrial respiration, two different models have been used: isolated mitochondria and cell culture of
human fibroblasts.

V01-10/13 73800-11
Results

Wheat and soy sprouts activate mitochondrial respiration in both models.

Mitochondrial model

The following chart shows how mitochondrial activity rises in a preparation of mitochondria, with an
increase in wheat and soy sprouts concentration (ppm) (chart 1). In this experiment, mitochondria were
pre-incubated with the active ingredient for 15-18 hours.

Mitochondria
40
35
Mitochondrial activity (%)

30
25
20
15
10
5
0
0.6 1.2 2.4 4
Sprouts extract (ppm)
Chart 1. Mitochondrial activity in mitochondria.

Model of human skin fibroblasts

Chart 2 shows the rise of mitochondrial activity in cultured fibroblasts due to the application of wheat and
soy sprouts. In this experiment, fibroblasts were pre-incubated with the active ingredient for 15-18 hours.

V01-10/13 73800-12
Fibroblasts
200
Mitochondrial activity (%)

150

100

50

0
0.42 1.38
Sprouts extract (ppm)

Chart 2. Mitochondrial activity in fibroblasts.

Sprouts increase cellular activity

2. BAICALIN: SENESCENCE

The effect of baicalin on cell cultures of primary human fibroblasts was assessed to observe:

TERT activation.
The effect on cell senescence.

Results

TERT activation

Fibroblast cultures were treated with baicalin for 24 hours. The results are expressed as the percentage of
luciferase activity relative to untreated cells (control). It is demonstrated that baicalin activates TERT in
primary fibroblasts.

V01-10/13 73800-13
300

250
TERT activation
200

150

100

50

0
Control 1 M baicalin 3 M baicalin 10 M baicalin

Chart 3. TERT activation due to baicalin (luminescence).

Cell senescence

To demonstrate the effect on cell senescence, human fibroblasts cultures were treated with baicalin,
beginning with cultures that were in an exponential growth phase until they stopped growing upon
reaching senescence.

It was demonstrated that 5 additional cell divisions took place in treated cells, compared to control, before
entering senescence. Therefore, baicalin has the ability to delay the entry into senescence of human
fibroblasts, as it increases the number of duplications by 10%, considering that the total number of
replications of a fibroblast is 50 (Schneider & Mitsui, 1976).

Baicalin delays cellular senescence

Due to the combination of the sprouts and baicalin, Baicapil is a product capable of:

Increasing hair growth.


Increasing hair density.
Reducing hair loss.

V01-10/13 73800-14
IN VIVO EFFICACY

PROTOCOL

The efficacy in regeneration and against hair loss of Baicapil has been demonstrated in an in vivo efficacy
study. To this end, a hair lotion at 3% of Baicapil was tested versus another lotion without active
ingredient (placebo).

This double-blind study involved 61 volunteers with Mediterranean Caucasian hair, 17 men and 44 women
aged between 18 and 60, randomly distributed between the placebo and Baicapil groups.

30 volunteers applied the placebo and 31 applied Baicapil on the scalp daily for 6 months of study.
Volunteers washed their hair every other day using a neutral formula shampoo. No other product against
hair loss was applied on the scalp during this study.

To evaluate the efficacy in regeneration and against hair loss of Baicapil, the following assessments were
made:

1. Assessment of the ratio between the anagen and telogen phases using a trichogram.
2. Assessment of hair density using scalp microphotography.
3. Assessment of hair loss using the washing and combing test.
4. Assessment of overall hair condition using photography.

The tests have been carried out by specialists in hair treatments and the assessments have been performed
by a specialist in trichology. All assessments have been performed at day 0 and day 180 of the study.
Additionally, the washing and combing test was performed on day 90 of the study.

1. RATIO BETWEEN THE ANAGEN AND TELOGEN PHASES

The assessment of the anagen and telogen phases of hair follicles consists in the direct observation of
follicles under the microscope and in identifying the phase according to the characteristics of each follicle
(sheath hydration and development, matrix condition and pigmentation, follicle appearance).

V01-10/13 73800-15
To assess the percentage of follicles in anagen phase versus follicles in telogen phase, a certain number of
hairs (between 15 and 25 hairs) is randomly extracted from the scalp using traction (always from the same
area) to be subjected to microscopic study (observation and photography).

The results are expressed as the number of follicles in the anagen (A) or telogen (T) phase, their percentage
in relation to all the hairs extracted from the volunteer, and the ratio of hair in anagen and telogen phase
(A/T).

Nowadays, experts observe that the ratio of hair in anagen and telogen phase (A/T) on healthy scalp is
rarely above 6. Therefore, many efficacy studies consider a result of A/T 4 as indicative of normal
condition.

The observation of follicles under the microscope shows that their condition substantially improves in the
group treated with Baicapil. An example of this improvement can be seen in fig. 3. This figure shows the
follicles collected from the same volunteer at the beginning (T0) and at the end (T180) of the study. Both
follicles are in the anagen phase, but much more intense activity in the matrix area and good sheath
development (more robust and thicker) can be observed in the follicle extracted at the end of the study,
compared to the image taken at the beginning of the study. Moreover, the bulb removed at the end of the
study is visibly larger and hair is clearly thicker compared to the initial picture.

T0 T180

Fig. 3. Microscopic images of two follicles in anagen phase collected from the same volunteer at the beginning and at the end of
the application of Baicapil. A visible improvement in the condition and activity of the follicle can be seen, together with an
increase in hair thickness.

V01-10/13 73800-16
At the end of the treatment, the number of follicles in the anagen and telogen phase was determined:

Volunteers who applied Baicapil have presented an average of 12.7% more anagen hair
compared to the beginning of the study. Placebo treatment has also resulted in a slight increase,
although in this case the difference has only been 2.0% compared to the beginning of the study.
Therefore, at the end of the study the difference in improvement between Baicapil and placebo
has been 10.7 percentage points, a statistically significant improvement (chart 4).

% anagen T180 vs. T0


14 12.7%
12
10
10.7
8
6
4
2.0%
2
0
PLACEBO BAICAPIL

Chart 4. Improvement of the percentage of the anagen hairs as a result of the application of placebo and Baicapil.

In the case of telogen hair count, volunteers who applied Baicapil have presented an average of
27.2% less telogen hair at the end of the study, compared to baseline. In the placebo group, the
number of the telogen hair has increased by 6.9%. Therefore, at the end of the study the difference
in improvement between Baicapil and placebo has been 34.1 percentage points (chart 5).

V01-10/13 73800-17
% telogen T180 vs. T0
PLACEBO BAICAPIL
10 6.9%
5
0
-5
-10
-15 34.1
-20
-25
-30 -27.2%
Chart 5. Improvement in the percentage of the telogen hair as a result of the application of placebo and Baicapil.

Finally, the anagen/telogen hair ratio (A/T ratio) has increased after the application of Baicapil from 3.5
at the beginning of the study to 5.9 at the end. This change has been virtually undetectable in the placebo
group (A/T was 2.8 at the beginning and 2.9 at the end of the study) (chart 6). This means a 68.6% increase
in the A/T ratio compared to the beginning of the study with Baicapil and only a 3.6% increase in the
placebo group (chart 7).

Changes in the A/T ratio % A/T T180 vs. T0


7 5.9 80
6
68.6%
70
5 60
4 3.5 50
2.9
3 2.8 40
2 30
20
1
10 3.6%
0
0
Day 0 Day 180
PLACEBO BAICAPIL
PLACEBO BAICAPIL

Chart 7. A/T ratio percentage improvement as a result of


Chart 6. Changes detected in the A/T ratio during the six months
placebo and Baicapil application after six months of study.
of application of Baicapil and placebo.

As shown in chart 6, Baicapil has increased the A/T ratio to 5.9, indicating the activation of telogen hair
follicles, the extension of the anagen phase, and leading to a healthier scalp.

Baicapil stimulates hair growth

V01-10/13 73800-18
2. HAIR DENSITY

Hair density (number of hairs per surface unit) has been assessed using the scalp images taken with the
microcamera. These images are automatically transferred to specialized software that allows visible hair
counts in the scalp surface defined unit.

Baicapil has increased hair density by 18% compared to the beginning of the study. This result has been
6.7 percentage points average better than that obtained for placebo (chart 8).

% density T180 vs. T0


20
18%
18 6.7
16
14
12 11.3%

10
8
6
4
2
0
PLACEBO BAICAPIL
Chart 8. Improvement in hair density obtained during the 6 months of the study.

Below are microphotographs of the scalp of volunteers who applied Baicapil during 6 months. The first
row shows photographs taken at the beginning (T0) of the study. Photographs taken at 6 months of study
(T180) are shown on the second row.

We can see the visible improvement in hair density and thickness after the application of Baicapil
observed in several volunteers (fig. 4):

Volunteer A 22% increase in hair density, from 182.98 hairs cm to 222.75 hairs cm .
2 2

Volunteer B 12% increase in the number of hairs, from 99.44 hairs cm to 111.28 hairs cm .
2 2

Volunteer C 28% increase in the number of hairs, from 155.13 hairs cm to 198.89 hairs cm .
2 2

V01-10/13 73800-19
+22% VOLUNTEER A +12% VOLUNTEER B +28% VOLUNTEER C

Fig. 4. Microphotographs of the scalp of volunteers who applied Baicapil.

Baicapil increases hair density and thickness with volumizing effect

3. HAIR LOSS

The efficacy of Baicapil against hair loss has been finally confirmed using the combing and washing test. In
this assay, the number of hairs that are shed from the scalp during combing and its subsequent washing
under standardized conditions is determined.

After 3 months of Baicapil application, a 60.6% reduction in hair loss compared to the beginning of the
study has been observed (chart 9). This result has been slightly more moderate after 6 months of treatment
(50.9% reduction in hair loss, chart 10) as a result of the adaptation of the hair follicle metabolism to the
daily contribution of active ingredient. Placebo also improved the condition of the follicles, although the
reduction in hair loss was much less pronounced than with Baicapil (chart 9 and 10).

V01-10/13 73800-20
Baicapil substantially improves the condition of follicles, resulting in better follicle anchoring to the
scalp.

% hair loss T90 vs. T0 % hair loss T180 vs. T0


PLACEBO BAICAPIL PLACEBO BAICAPIL
0 0
-10 -10
-20
-20
-30
-30
-40
-37.8% -40
-50 -37.4%
-60 -50
22.8
-70 -60.6% -60
13.5 -50.9%

Chart 9. Improvement in hair loss observed after Chart 10. Improvement in hair loss observed
three months of placebo and Baicapil after six months of placebo and Baicapil
application. application.

Baicapil reduces hair loss

4. OVERALL HAIR CONDITION

The objective of this assessment was to check whether the application of Baicapil leads to a visible
improvement of hair density in volunteers.

Several pictures of the top of the scalp of each volunteer were taken at day 0 and 180 of the study. The
images show the hairline and crown.

On volunteers who applied Baicapil considerable improvements in hair quantity and quality have been
observed (fig. 5).

V01-10/13 73800-21
T0 T180

Fig. 5. Example of improvement in overall hair condition in a volunteer after the application of Baicapil for six months.

Baicapil visibly improves hair quantity and quality

* The final formula of Baicapil contains arginine, used as a stabilizing agent. However, arginine is also
known for its efficacy against hair loss. In this case, it was decided that, in order not to distort the results of
our in vivo study, arginine would be removed from the hair lotion with Baicapil used for these tests.

CONCLUSION

Baicapil increases cellular energy and protects follicle


fibroblasts against oxidative stress and senescence, thus
improving follicular activity and extending the anagen phase of
the hair cycle.

In addition, it has been demonstrated in vivo that it improves


the ratio of anagen hair versus telogen hair and increases hair
growth and density. Moreover, it reduces hair loss, visibly
improving hair quantity and quality.

Baicapil is an active ingredient that reduces hair loss, stimulating hair growth and improving its overall
condition.

V01-10/13 73800-22
COSMETIC APPLICATIONS

Products against hair loss.


Hair care lines: tonics, serums, conditioners, masks, shampoos.
Stimulating products for hair growth.
Anti-aging hair product lines.

RECOMMENDED DOSAGE

The recommended dosage is between 2 and 4 %.

BIBLIOGRAPHY

Adachi K. et al. Activity of Glucose-6-phosphate 1-Dehydrogenase in Hair Follicles with Male-pattern


Alopecia. Biosci. Biotechnol. Biochem. 1999, 63(12):2219-2221.

Adachi K. et al. Human Hair Follicles: Metabolism and Control Mechanisms. J. Soc. Cosmeti. Chem. 1970,
21:901-924.

Ahmed S. et al. Telomerase does not counteract telomere shortening but protects mitochondrial function
under oxidative stress. J Cell Sci. 2008, 121(Pt 7):1046-53.

Choi J. et al. TERT Promotes Epithelial Proliferation through Transcriptional Control of a Myc- and Wnt-
Related Developmental Program. PLoS Genet. 2008, 4(1):e10.

Flores I. et al. Effects of telomerase and telomere length on epidermal stem cell behavior. Science. 2005,
309(5738):1253-1256.

Goh C., Zippin J.H. Androgenetic alopecia: diagnosis and treatment with a focus on recent genetic
implications. J Drugs Dermatol. 2009, 8(2):185-192.

Haendeler J. et al. Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA
and function from damage. Arterioscler Thromb Vasc Biol. 2009, 29:929-935.

V01-10/13 73800-23
Kwack M.H. et al. Wnt5a attenuates Wnt/-catenin signalling in human dermal papilla cells. Exp Dermatol.
2013, 22(3):229-31.

Myung P.S. et al. Epithelial Wnt ligand secretion is required for adult hair follicle growth and regeneration. J
Invest Dermatol. 2013, 133(1):31-41.

Paus R., Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999, 341(7):491-497.

Plikus M.V. New activators and inhibitors in the hair cycle clock: targeting stem cells' state of competence. J
Invest Dermatol. 2012, 132(5):1321-1324.

Restrepo, R. Anatoma microscpica del folculo piloso. Rev Asoc Col Dermatol. 2010, 18(3):123-138.

Ritti L. et al. Hedgehog signaling maintains hair follicle stem cell phenotype in young and aged human skin.
Aging Cell. 2009, 8(6):738-51.

Rompolas P. et al. Live imaging of stem cell and progeny behaviour in physiological hair-follicle
regeneration. Nature. 2012, 487(7408):496-499.

Sarin K. et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature. 2005,
436:1048-1052.

Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl.
Acad. Sci. 1976, 73(10):3584-3588.

Stutte G. et al. Carbon Dioxide Enrichment Enhances Growth and Flavonoid Content of Two Scutellaria
species. J. Amer. Soc. Hort. Sci. 2008, 133(5):631638.

Treb. R. Oxidative Stress in Ageing of Hair. Int J Trichology. 2009, 1(1):6-14.

Upton J.H. et al. Oxidative stress and cell senescence in androgenetic alopecia (AGA). Journal of Investigative
Dermatology. 2013, 133:1398.

V01-10/13 73800-24
PROVITAL. S.A.
Pol. Ind. Can Salvatella
Gorgs Llad, 200
08210 Barber del Valls
Barcelona (Espaa)
Tel. (+34) 93 719 23 50

info@provitalgroup.com
www.provitalgroup.com